COVID-19

New and Noteworthy

Poll: Most Adults Do Not Expect to Get a COVID-19 Shot This Fall; Many Parents Confused About Recommendations for Children

As federal vaccine policy changes, this poll finds that most adults do not expect to get a COVID-19 vaccine this fall , and many parents are confused and uncertain about whether the vaccine is recommended for healthy children this year. About one in adults nationally say the changes to vaccine policy are making people safer, while more than a third say they are making people less safe.

Additional Resources

Global COVID-19 Tracker

This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths.

COVID-19 and Related State Data

Use this tool to create custom reports of COVID-19 and related state data. Group COVID-19 cases and deaths with indicators like total hospitalizations, vaccinations and mental illness.

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

Filter

101 - 110 of 777 Results

  • A Fall Update on COVID-19 Cases and Deaths, Vaccinations, and Treatments by Race/Ethnicity

    News Release

    KFF has updated its national analysis of race/ethnicity data of COVID-19 cases and deaths, vaccinations, and treatments as concerns grow over a potential increase in COVID-19 cases during winter and upcoming holiday gatherings and the low take-up of the COVID-19 bivalent booster vaccine among the eligible public. Despite earlier progress narrowing disparities in COVID-19 vaccination, new disparities have emerged in take-up of boosters and treatment. Federal data from earlier this month indicates that, among the…

  • COVID-19 Cases and Deaths, Vaccinations, and Treatments by Race/Ethnicity as of Fall 2022

    Issue Brief

    Over the course of the pandemic, racial disparities in cases and deaths have widened and narrowed. However, overall, Black, Hispanic, and American Indian and Alaska Native (AIAN) people have borne the heaviest health impacts of the pandemic. While Black and Hispanic people were less likely than their White counterparts to receive a vaccine during the initial phases of the vaccination rollout, these disparities have narrowed over time and reversed for Hispanic people.

  • Cost of COVID-19 Hospital Admissions among People with Private Health Coverage

    Issue Brief

    This analysis examines the cost of COVID-19 treatment for inpatient care among people with health coverage through large employers. It finds that in 2020, COVID-19 hospitalizations cost an average of $41,611, including an average out-of-pocket payment of $1,280 for people with large employer coverage.

  • COVID-19 leading cause of death ranking

    Issue Brief

    This updated analysis examines COVID-19's effect on mortality rates, and estimates that in January 2022, COVID-19 was number two on the list of leading causes of death in the U.S.

  • 2022 Employer Health Benefits Survey

    Report

    This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, worker contributions, cost-sharing provisions, offer rates, and more. This year’s report also looks at how employers are addressing a growing need for mental health services.

  • With Government Funding Running Out, Americans Could Soon Face New Challenges in Accessing COVID-19 Treatments and Testing

    News Release

    A new KFF brief analyzes how the accessibility and cost of COVID-19 vaccines, treatments, and tests will change after the current government supply is depleted and the public health emergency ends. The Biden Administration has announced that it will have to end its purchase and distribution of COVID supplies as government funding is depleted. The public health emergency was recently extended for 90 additional days but is widely expected to end next year. These developments…

  • The Commercialization of COVID

    Event Date:
    Event

    On Wednesday, October 19th, a panel of experts joined series moderator Larry Levitt in a 45-minute discussion exploring the government’s plan to transition the distribution of COVID tests, vaccines, and therapeutics to the commercial market and its potential implications for consumers and insurers.